1-4 of 4
Huili Lu
Close
Sort by
Journal Articles

CXCL9 Contributes To Chemotherapy-Induced Acute Intestinal Damage Through Proliferative Inhibition Of Epithelial Cells

Huili Lu, PhD, Hongyu Liu, Jiaqing Shen, Shunyan Weng, Lan Qian, Mingyuan Wu, Shunying Zhu, Yan Yu, Wei Han, Jianwei Zhu, Anja Moldenhauer, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 5563.
https://doi.org/10.1182/blood.V122.21.5563.5563
Published: 2013
Journal Articles

Activated expression of the chemokine Mig after chemotherapy contributes to chemotherapy-induced bone marrow suppression and lethal toxicity

Huili Lu, Shunying Zhu, Lan Qian, Di Xiang, Wu Zhang, Aifang Nie, Jin Gao, Mingyuan Wu, Jinming Gao, Bao Lu, Yan Yu, Wei Han, Anja Moldenhauer
Journal: Blood
Blood (2012) 119 (21): 4868–4877.
https://doi.org/10.1182/blood-2011-07-367581
Published: 2012
Includes: Supplemental data
Journal Articles

CXCL9 and IL32 Regulate Progenitor Expansion and Protect Hematopoietic Progenitor Cells From Chemotherapy

Huili Lu, PhD, Wei Han, Abdulgabar Salama, Anja Moldenhauer, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 1316.
https://doi.org/10.1182/blood.V118.21.1316.1316
Published: 2011
Journal Articles

Gro 3, Osteoprotegerin and Interleukin 32 Function As Hematopoietic Growth Factors

Anja Moldenhauer, MD, PhD, Matthias Futschik, PhD, Huili Lu, PhD, Melanie Helmig, Patricc Götze, Gürkan Bal, Martin Zenke, Wei Han, Abdulgabar Salama
Journal: Blood
Blood (2011) 118 (21): 4784.
https://doi.org/10.1182/blood.V118.21.4784.4784
Published: 2011